Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria

Malaria is one of the prevalent tropical diseases caused by the parasitic protozoan of the genus Plasmodium spp. With an estimated 228 million cases, it is a major public health concern with high incidence of morbidity and mortality worldwide. The emergence of drug-resistant parasites, inadequate ve...

Full description

Bibliographic Details
Main Authors: Lohitha Gujjari, Hamed Kalani, Sai Kiran Pindiprolu, Bhanu Prakash Arakareddy, Ganesh Yadagiri
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Parasite Epidemiology and Control
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405673122000083
_version_ 1818015125975597056
author Lohitha Gujjari
Hamed Kalani
Sai Kiran Pindiprolu
Bhanu Prakash Arakareddy
Ganesh Yadagiri
author_facet Lohitha Gujjari
Hamed Kalani
Sai Kiran Pindiprolu
Bhanu Prakash Arakareddy
Ganesh Yadagiri
author_sort Lohitha Gujjari
collection DOAJ
description Malaria is one of the prevalent tropical diseases caused by the parasitic protozoan of the genus Plasmodium spp. With an estimated 228 million cases, it is a major public health concern with high incidence of morbidity and mortality worldwide. The emergence of drug-resistant parasites, inadequate vector control measures, and the non-availability of effective vaccine(s) against malaria pose a serious challenge to malaria eradication especially in underdeveloped and developing countries. Malaria treatment and control comprehensively relies on chemical compounds, which encompass various complications, including severe toxic effects, emergence of drug resistance, and high cost of therapy. To overcome the clinical failures of anti-malarial chemotherapy, a new drug development is of an immediate need. However, the drug discovery and development process is expensive and time consuming. In such a scenario, nanotechnological strategies may offer promising alternative approach for the treatment and control of malaria, with improved efficacy and safety. Nanotechnology based formulations of existing anti-malarial chemotherapeutic agents prove to exceed the limitations of existing therapies in relation to optimum therapeutic benefits, safety, and cost effectiveness, which indeed advances the patient's compliance in treatment. In this review, the shortcomings of malaria therapeutics and necessity of nanotechnological strategies for treating malaria were discussed.
first_indexed 2024-04-14T06:53:55Z
format Article
id doaj.art-00c6e44f4c5244948f295f1b83f2d3cc
institution Directory Open Access Journal
issn 2405-6731
language English
last_indexed 2024-04-14T06:53:55Z
publishDate 2022-05-01
publisher Elsevier
record_format Article
series Parasite Epidemiology and Control
spelling doaj.art-00c6e44f4c5244948f295f1b83f2d3cc2022-12-22T02:06:57ZengElsevierParasite Epidemiology and Control2405-67312022-05-0117e00244Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malariaLohitha Gujjari0Hamed Kalani1Sai Kiran Pindiprolu2Bhanu Prakash Arakareddy3Ganesh Yadagiri4Centre of Infectious Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S. A. S. Nagar, Punjab 160 062, India; Department of Entomology, The Ohio State University, Ohio Agricultural Research and Development Center, 1680 Madison Avenue, Wooster, OH 44691, USAInfectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, IranDepartment of Pharmacology, School of Pharmaceutical Sciences and Technologies, Jawaharlal Nehru Technological University, Kakinada, Andhra Pradesh 533003, IndiaDepartment of Pharmacology, Bharat School of Pharmacy, Mangalpally, Telengana 501510, IndiaDepartment of Pharmacology, School of Pharmaceutical Sciences and Technologies, Jawaharlal Nehru Technological University, Kakinada, Andhra Pradesh 533003, India; Centre for Food Animal Health, The Ohio State University, Ohio Agricultural Research and Development Center, 1680 Madison Avenue, Wooster, OH 44691, USA; Corresponding author at: Department of Pharmacology, School of Pharmaceutical Sciences and Technologies, Jawaharlal Nehru Technological University, Kakinada, Andhra Pradesh 533003, India.Malaria is one of the prevalent tropical diseases caused by the parasitic protozoan of the genus Plasmodium spp. With an estimated 228 million cases, it is a major public health concern with high incidence of morbidity and mortality worldwide. The emergence of drug-resistant parasites, inadequate vector control measures, and the non-availability of effective vaccine(s) against malaria pose a serious challenge to malaria eradication especially in underdeveloped and developing countries. Malaria treatment and control comprehensively relies on chemical compounds, which encompass various complications, including severe toxic effects, emergence of drug resistance, and high cost of therapy. To overcome the clinical failures of anti-malarial chemotherapy, a new drug development is of an immediate need. However, the drug discovery and development process is expensive and time consuming. In such a scenario, nanotechnological strategies may offer promising alternative approach for the treatment and control of malaria, with improved efficacy and safety. Nanotechnology based formulations of existing anti-malarial chemotherapeutic agents prove to exceed the limitations of existing therapies in relation to optimum therapeutic benefits, safety, and cost effectiveness, which indeed advances the patient's compliance in treatment. In this review, the shortcomings of malaria therapeutics and necessity of nanotechnological strategies for treating malaria were discussed.http://www.sciencedirect.com/science/article/pii/S2405673122000083Anti-malarialsChemotherapyDrug resistanceEfficacyMalariaNanotechnological approaches
spellingShingle Lohitha Gujjari
Hamed Kalani
Sai Kiran Pindiprolu
Bhanu Prakash Arakareddy
Ganesh Yadagiri
Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria
Parasite Epidemiology and Control
Anti-malarials
Chemotherapy
Drug resistance
Efficacy
Malaria
Nanotechnological approaches
title Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria
title_full Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria
title_fullStr Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria
title_full_unstemmed Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria
title_short Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria
title_sort current challenges and nanotechnology based pharmaceutical strategies for the treatment and control of malaria
topic Anti-malarials
Chemotherapy
Drug resistance
Efficacy
Malaria
Nanotechnological approaches
url http://www.sciencedirect.com/science/article/pii/S2405673122000083
work_keys_str_mv AT lohithagujjari currentchallengesandnanotechnologybasedpharmaceuticalstrategiesforthetreatmentandcontrolofmalaria
AT hamedkalani currentchallengesandnanotechnologybasedpharmaceuticalstrategiesforthetreatmentandcontrolofmalaria
AT saikiranpindiprolu currentchallengesandnanotechnologybasedpharmaceuticalstrategiesforthetreatmentandcontrolofmalaria
AT bhanuprakasharakareddy currentchallengesandnanotechnologybasedpharmaceuticalstrategiesforthetreatmentandcontrolofmalaria
AT ganeshyadagiri currentchallengesandnanotechnologybasedpharmaceuticalstrategiesforthetreatmentandcontrolofmalaria